Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 741: Continuous scrutiny of factors that determine the occurrence and distribution of disease and other conditions of ill health is the definition of what?

A. Monitoring
B. Surveillance (Correct Answer)
C. Disease control
D. System analysis

Explanation: ### Explanation **Correct Answer: B. Surveillance** **Why it is correct:** The definition provided is the classic WHO definition of **Surveillance**. In epidemiology, surveillance is the "continuous scrutiny" of all aspects of occurrence and distribution of a disease. It involves the systematic collection, analysis, and interpretation of health data, followed by the **timely dissemination** of this information to those who need to know, so that action can be taken. Key elements include its ongoing (continuous) nature and the link between data and public health action. **Why other options are incorrect:** * **A. Monitoring:** This is the performance and analysis of routine measurements aimed at detecting changes in the environment or health status of a population. Unlike surveillance, monitoring is usually a periodic or episodic measurement of performance against a standard, rather than a continuous scrutiny of disease determinants. * **C. Disease Control:** This refers to the operations aimed at reducing the incidence, duration, and effects of a disease to a level where it is no longer a public health problem. Surveillance is a *tool* used for disease control, not the definition of the process itself. * **D. System Analysis:** This is a management technique used to evaluate the efficiency and effectiveness of an organization or a health system. It focuses on inputs, processes, and outputs rather than the epidemiological distribution of disease. **NEET-PG High-Yield Pearls:** * **Surveillance vs. Monitoring:** Remember the mnemonic: **Surveillance = Information for Action.** Monitoring is checking if a program is "on track." * **Passive Surveillance:** Most common; health authorities receive reports from clinics/hospitals (e.g., routine OPD data). * **Active Surveillance:** Health staff go into the field to identify cases (e.g., searching for AFP cases in Polio programs). * **Sentinel Surveillance:** Monitoring a specific sub-population or site to identify trends in the larger population (e.g., HIV sentinel surveillance). * **The "Feedback Loop":** Surveillance is incomplete without the dissemination of data back to those who collected it.

Question 742: What does one DALY signify?

A. One year of disease-free life
B. One lost year of healthy life (Correct Answer)
C. One month of bed-ridden life
D. None of these

Explanation: ### Explanation **1. Why the Correct Answer is Right:** The **Disability-Adjusted Life Year (DALY)** is a summary measure of population health used to quantify the burden of disease. One DALY represents the loss of the equivalent of **one year of full health**. It is a composite indicator calculated by the sum of two components: * **YLL (Years of Life Lost):** Due to premature mortality (dying before the expected age). * **YLD (Years Lived with Disability):** Due to living with a disease or injury. **Formula:** $DALY = YLL + YLD$. It effectively measures the "gap" between current health status and an ideal situation where the entire population lives to an advanced age, free of disease and disability. **2. Why the Other Options are Wrong:** * **Option A:** A "disease-free year" refers to healthy life expectancy, not a measure of loss or burden. DALY specifically measures *lost* time. * **Option C:** DALY is measured in **years**, not months. Furthermore, it accounts for all levels of disability (from mild impairment to severe), not just "bed-ridden" states. * **Option D:** This is incorrect because Option B accurately defines the metric. **3. NEET-PG High-Yield Pearls:** * **Origin:** DALY was originally developed by Christopher Murray and Lopez for the Global Burden of Disease (GBD) study in 1990. * **QALY vs. DALY:** While DALY measures the **burden** of disease (negative), **QALY (Quality-Adjusted Life Year)** measures the **benefit** or outcome of a medical intervention (positive). * **Global Trend:** Currently, non-communicable diseases (NCDs) contribute to a larger share of global DALYs than communicable diseases. * **Weighting:** In DALY calculations, different health states are assigned a "disability weight" ranging from 0 (perfect health) to 1 (death).

Question 743: Which demographic statistic is considered when calculating the Net Reproduction Rate (NRR)?

A. Gross Enrollment Ratio (GER)
B. Net Reproduction Rate (NRR) (Correct Answer)
C. Total Fertility Rate (TFR)
D. Gross Maternal Fertility Rate (GMFR)

Explanation: ### Explanation The **Net Reproduction Rate (NRR)** is a key demographic indicator used to measure the number of daughters a newborn girl will bear during her lifetime, assuming she is subject to fixed age-specific fertility and mortality rates. **Why the correct answer is right:** The NRR is the demographic statistic used to define **Replacement Level Fertility**. An NRR of **1.0** indicates that a mother is being replaced by exactly one daughter, leading to a stable population in the long run. Unlike the Total Fertility Rate (TFR), the NRR accounts for **mortality**—specifically, the probability that a female child will survive to her reproductive years. **Analysis of Incorrect Options:** * **A. Gross Enrollment Ratio (GER):** This is an educational statistic, not a demographic fertility measure. it represents the number of students enrolled in a specific level of education regardless of age. * **C. Total Fertility Rate (TFR):** While TFR measures the average number of children a woman would have, it does not account for the survival of the offspring or the sex of the child. TFR of 2.1 is generally required to achieve an NRR of 1. * **D. Gross Maternal Fertility Rate (GMFR):** This is not a standard demographic term. It is likely a distractor confused with the General Fertility Rate (GFR), which relates births to the number of women in the reproductive age group (15-44/49 years). **High-Yield NEET-PG Pearls:** * **NRR = 1** is the demographic goal of the National Health Policy in India (achieved when TFR is approx. 2.1). * If **NRR < 1**, the population will eventually decline. * The **Gross Reproduction Rate (GRR)** is similar to NRR but **ignores mortality** (it assumes all girls survive to the end of their reproductive period). * **NRR is always lower than GRR** because it accounts for the risk of death before completing the reproductive cycle.

Question 744: In 2013, which country was not polio endemic?

A. Afghanistan
B. Pakistan
C. Kenya (Correct Answer)
D. Nigeria

Explanation: **Explanation:** The core concept tested here is the distinction between **Endemic countries** (where indigenous Wild Poliovirus transmission has never been interrupted) and **Outbreak/Imported cases** countries. **Why Kenya is the correct answer:** In 2013, Kenya was classified as a **"re-infected"** or **"outbreak"** country, not an endemic one. While Kenya did report cases of Wild Poliovirus type 1 (WPV1) in 2013 (primarily in the Horn of Africa outbreak affecting the Dadaab refugee camp), these were due to importation from Somalia. Kenya had successfully interrupted indigenous transmission years prior. **Analysis of Incorrect Options:** * **Afghanistan, Pakistan, and Nigeria:** In 2013, these three countries constituted the **"Endemic Trio."** They were the only countries in the world that had never successfully stopped the transmission of indigenous Wild Poliovirus. * *Note:* Nigeria was later removed from this list, and the WHO African Region was declared Polio-free in 2020. Currently, only Afghanistan and Pakistan remain endemic. **NEET-PG High-Yield Pearls:** * **Current Endemic Countries (2024):** Only Afghanistan and Pakistan. * **Last Case of Polio in India:** Reported on **January 13, 2011**, in Howrah, West Bengal. * **India’s Certification:** India was declared "Polio Free" by the WHO on **March 27, 2014**. * **Eradicated Strains:** WPV Type 2 (declared eradicated in 2015) and WPV Type 3 (declared eradicated in 2019). Only WPV Type 1 remains in circulation. * **Vaccine of Choice:** India currently uses **bOPV** (containing types 1 and 3) in campaigns and **fIPV** (fractional Inactivated Poliovirus Vaccine) in the routine immunization schedule.

Question 745: Which of the following is called a carrier who received the source of infection from other carriers?

A. Incubatory carrier
B. Convalescent carrier
C. Healthy carrier
D. None of the above (Correct Answer)

Explanation: ### Explanation The correct answer is **None of the above** because the description provided in the question refers to a **"Pseudo-carrier."** In epidemiology, a pseudo-carrier is an individual who acquires the infectious agent from another carrier rather than from a clinical case. #### Why the options are incorrect: * **Incubatory Carrier:** This is a person who sheds the infectious agent during the **incubation period** of the disease (before clinical symptoms appear). Examples include Measles, Mumps, and Hepatitis B. * **Convalescent Carrier:** This is a person who continues to shed the infectious agent during the **period of recovery** (after clinical symptoms have subsided). Examples include Typhoid fever and Diphtheria. * **Healthy Carrier:** This is an individual who harbors the pathogen but never manifests the clinical disease (subclinical infection). They act as a silent reservoir. Example: Cholera, Meningococcus. #### High-Yield Clinical Pearls for NEET-PG: * **Definition of a Carrier:** A person who harbors a specific infectious agent without discernible clinical disease and serves as a potential source of infection. * **Duration-based Classification:** * **Temporary:** Shedding for a short period. * **Chronic:** Shedding for indefinite periods (e.g., **Typhoid Mary**). * **Portal of Exit:** Carriers can be classified as urinary, intestinal, respiratory, or cutaneous based on how the agent leaves the body. * **Epidemiological Importance:** Carriers are often more dangerous than cases because they are mobile, unrecognized, and continue their normal activities, facilitating the spread of infection.

Question 746: Which of the following epidemiological characteristics are used to measure the ability of biological agents to induce clinically apparent illness?

A. Characteristic 1 and Characteristic 2 (Correct Answer)
B. Characteristic 2 only
C. Characteristic 3 only
D. Characteristic 2 and Characteristic 3

Explanation: In epidemiology, the relationship between a host and an infectious agent is defined by specific metrics that measure the agent's behavior. To measure the ability of an agent to induce **clinically apparent illness**, we look at **Pathogenicity** and **Virulence**. ### **Explanation of the Correct Answer** * **Pathogenicity:** This is the ability of an infectious agent to produce disease in a host. It is measured as the ratio of the number of persons developing clinical illness to the total number of persons exposed to the infection. * **Virulence:** This refers to the degree of pathogenicity or the severity of the disease produced. It is often measured by the **Case Fatality Rate (CFR)**. * Both characteristics focus on the transition from subclinical infection to overt clinical disease (symptoms and severity). ### **Analysis of Incorrect Options** * **Infectivity (Characteristic 3):** This is the ability of an agent to enter, survive, and multiply in a host. It measures the proportion of exposed persons who become *infected* (regardless of whether they show symptoms). It is a measure of "transmission" rather than "illness." * **Options B, C, and D** are incorrect because they either exclude Pathogenicity/Virulence or incorrectly include Infectivity as a measure of clinical illness. ### **NEET-PG High-Yield Pearls** * **Infectivity:** Measured by the **Secondary Attack Rate (SAR)**. * **Pathogenicity:** Distinguishes "Infection" from "Disease." * **Virulence:** Distinguishes "Disease" from "Severe/Fatal Disease." * **Iceberg Phenomenon:** The "tip" represents clinical cases (Pathogenicity/Virulence), while the "submerged portion" represents subclinical cases and carriers (Infectivity). * **Serial Interval:** The gap between the onset of primary and secondary cases; useful for predicting the spread of an epidemic.

Question 747: What is true about a case-control study?

A. It is less expensive. (Correct Answer)
B. Individuals with the disease and without the disease are compared.
C. Attributable risk is estimated.
D. None of the above.

Explanation: **Explanation:** In a **Case-Control Study**, researchers identify individuals with a specific outcome (Cases) and compare them to individuals without that outcome (Controls) to look back retrospectively at exposure history. **Why Option A is Correct:** Case-control studies are inherently **less expensive** and faster than cohort studies. Because the outcome has already occurred, there is no need for long-term follow-up, large sample sizes, or expensive diagnostic monitoring over years. This makes them the design of choice for studying rare diseases or diseases with long latency periods. **Analysis of Incorrect Options:** * **Option B:** While it is true that individuals with and without the disease are compared, this is the *definition* of the study design rather than a specific advantage or unique "truth" in the context of comparative epidemiology questions. However, in many competitive exams, if "Less expensive" is an option, it is prioritized as the hallmark practical advantage. (Note: In some contexts, B is also technically true, but A is the classic textbook "advantage" tested). * **Option C:** **Attributable Risk** cannot be calculated in a case-control study because the incidence of the disease cannot be determined. Instead, we calculate the **Odds Ratio (OR)** as an estimate of relative risk. **High-Yield NEET-PG Pearls:** * **Direction:** Retrospective (Outcome to Exposure). * **Measure of Association:** Odds Ratio (OR). * **Best for:** Rare diseases and outbreaks. * **Bias:** Highly prone to **Recall Bias** and **Selection Bias**. * **Matching:** Done to eliminate the effects of confounding variables.

Question 748: Dracunculosis is most common in which Indian state?

A. Gujarat
B. Rajasthan (Correct Answer)
C. Madhya Pradesh
D. Orissa

Explanation: **Explanation:** **Dracunculiasis (Guinea Worm Disease)** was a major public health challenge in India until its successful eradication. Historically, the disease was highly endemic in arid and semi-arid regions where step-wells were the primary source of drinking water. 1. **Why Rajasthan is Correct:** Rajasthan was the most endemic state in India due to its geographical terrain and the widespread use of **step-wells (Baolis)**. The disease cycle involves the ingestion of water containing *Cyclops* (the intermediate host) infected with *Dracunculus medinensis* larvae. In Rajasthan, people would step into these wells to collect water, allowing the female worm to discharge larvae directly into the water source, thereby maintaining the transmission cycle. 2. **Why Other Options are Incorrect:** While Gujarat, Madhya Pradesh, and Orissa (along with Maharashtra, Karnataka, and Andhra Pradesh) were among the seven endemic states in India, the burden and persistence of the disease were significantly higher in Rajasthan due to its specific water-storage traditional practices. 3. **Clinical Pearls for NEET-PG:** * **Eradication Status:** India was declared **Guinea Worm Free** by the WHO on **February 15, 2000**. The last case in India was reported in July 1996 in Rajasthan (Jodhpur district). * **Intermediate Host:** *Cyclops* (Water flea). * **Definitive Host:** Man. * **Infective Stage:** 3rd stage L3 larva. * **Prevention:** The "Step-well to Draw-well" conversion strategy and the use of **Temephos (Abate)** to kill *Cyclops* were key to eradication. * **Global Status:** It is the first parasitic disease slated for global eradication. Currently, it remains endemic only in a few African countries (e.g., Chad, Ethiopia, South Sudan).

Question 749: The window period is defined as the time taken from:

A. Entry of a pathogen to the appearance of the first clinical symptom
B. Exposure to laboratory detection of the disease (Correct Answer)
C. Entry into a cell to the expulsion of the first viral particle
D. Infection to the point of maximum communicability

Explanation: ### Explanation **Correct Answer: B. Exposure to laboratory detection of the disease** The **Window Period** is the interval between the initial infection (exposure) and the time when the disease can be reliably detected by standard laboratory tests (such as antibodies or antigens). During this phase, the person is infected and potentially infectious, but diagnostic tests (like ELISA) may yield a **false negative** because the biomarkers have not yet reached detectable levels. This concept is most critically applied in HIV screening and blood transfusion safety. **Analysis of Incorrect Options:** * **Option A (Entry of pathogen to first clinical symptom):** This defines the **Incubation Period**. It is a clinical measure rather than a laboratory one. * **Option C (Entry into a cell to expulsion of first viral particle):** This defines the **Eclipse Phase**, a term used in virology to describe the time when the virus is replicating intracellularly and cannot be recovered from the host cell. * **Option D (Infection to maximum communicability):** This does not have a specific epidemiological name, though the period from infection to becoming infectious is known as the **Latent Period**. **NEET-PG High-Yield Pearls:** * **Generation Time:** The interval between the receipt of infection and maximal infectivity of the host (often coincides with the incubation period but is distinct). * **Serial Interval:** The time gap between the onset of the primary case and the onset of the secondary case. * **Iceberg Phenomenon:** The window period represents a portion of the "submerged" part of the iceberg (unseen cases). * **HIV Window Period:** With 4th generation ELISA (p24 antigen + antibody), the window period is reduced to approximately 14–21 days.

Question 750: Sullivan's index measures which of the following?

A. Mortality
B. Morbidity
C. Infectivity
D. Disability (Correct Answer)

Explanation: **Explanation:** **Sullivan’s Index** (also known as **Disability-Free Life Expectancy**) is a sophisticated health indicator used to measure the quality of life rather than just the quantity. It is calculated by subtracting the duration of bed disability and inability to perform major activities from the total life expectancy. 1. **Why Disability is Correct:** Sullivan’s Index specifically measures the **expectation of life free of disability**. It represents the average number of years a person can expect to live without chronic disease or disability. In the context of the Global Burden of Disease, it is one of the most advanced indicators used to assess the health status of a community by focusing on functional capacity. 2. **Why Other Options are Incorrect:** * **Mortality:** Mortality refers to death rates (e.g., Crude Death Rate). While Sullivan's Index uses life expectancy (a mortality-based data point) as a baseline, its primary purpose is to adjust that life expectancy for quality, not to measure death itself. * **Morbidity:** Morbidity refers to the presence of disease. While disability often results from morbidity, Sullivan’s Index specifically quantifies the *functional limitation* (disability) rather than the incidence or prevalence of the disease itself. * **Infectivity:** This is a characteristic of an infectious agent (the ability to enter and multiply in a host) and is unrelated to population health indices like Sullivan’s. **High-Yield Clinical Pearls for NEET-PG:** * **Formula:** Sullivan’s Index = Life Expectancy – Duration of disability/confinement. * **DALY (Disability Adjusted Life Years):** Another high-yield indicator. **1 DALY = 1 year of healthy life lost.** It combines YLL (Years of Life Lost) + YLD (Years Lived with Disability). * **HALE (Health-Adjusted Life Expectancy):** Formerly known as DALE; it is the equivalent number of years in full health that a newborn can expect to live. * **PQLI (Physical Quality of Life Index):** Includes Infant Mortality, Life Expectancy at Age 1, and Literacy (Scale 0-100). It does *not* include per capita income.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free